Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
PLoS One. 2022 Mar 1;17(3):e0264641. doi: 10.1371/journal.pone.0264641. eCollection 2022.
Intracranial germinoma (IG) rarely occurs in adults. Its optimal treatment strategy is unclear. We evaluated the outcomes of radiotherapy in adults with intracranial germinoma. Data of 29 adult patients (age, 18-52 years; median age, 24.3 years) with IG treated with radiotherapy at Taipei Veterans General Hospital were retrospectively reviewed. They were followed up for a median time of 5.9 years (range, 1.0-12.8 years). We used the Kaplan-Meier method to estimate the progression-free survival (PFS) and overall survival (OS), and univariate and multivariate Cox proportional hazards regression models to identify the factors affecting PFS. PFS and OS were compared between adult and pediatric patients with IG. The 1-, 3-, and 5-year PFS rates were 96.6%, 85.8%, and 77.8%, respectively, in the adult patients, and the OS rate were all 100%. Seven patients (24.1%) experienced recurrence, and in six of them, salvage therapy successfully controlled the disease. Two patients (6.9%) died after 5 years of follow-up due to disease progression and central pontine myelinolysis. In the univariate and multivariate Cox analysis, bifocal lesions had a significantly lower PFS than those with single lesions (p = 0.008). Kaplan-Meier survival analysis showed that adult patients had a poorer PFS (p = 0.06) and OS (p = 0.025) than pediatric patients. Our study showed bifocal lesions were associated with lower PFS than a single lesion among adult IG patients, and adult IG patients tended to have poorer PFS and OS compared to pediatric IG patients. For adult patients with bifocal IG, we recommend treatment with craniospinal irradiation, whole ventricle irradiation (WVI) with chemotherapy, or frequent spine images follow-up for patients who received only WVI.
颅内生殖细胞瘤(IG)在成人中很少见。其最佳治疗策略尚不清楚。我们评估了放疗在成人颅内生殖细胞瘤中的疗效。回顾性分析了台北荣民总医院 29 例接受放疗的成人颅内生殖细胞瘤患者的资料,患者年龄 18-52 岁,中位年龄 24.3 岁。中位随访时间为 5.9 年(范围 1.0-12.8 年)。采用 Kaplan-Meier 法估计无进展生存期(PFS)和总生存期(OS),并采用单因素和多因素 Cox 比例风险回归模型分析影响 PFS 的因素。比较了成人和儿童 IG 患者的 PFS 和 OS。成人患者的 1、3 和 5 年 PFS 率分别为 96.6%、85.8%和 77.8%,OS 率均为 100%。7 例(24.1%)患者复发,其中 6 例挽救性治疗成功控制了疾病。2 例患者(6.9%)在随访 5 年后因疾病进展和脑桥中央髓鞘溶解症死亡。单因素和多因素 Cox 分析显示,多发病灶患者的 PFS 明显低于单发患者(p=0.008)。Kaplan-Meier 生存分析显示,成人患者的 PFS(p=0.06)和 OS(p=0.025)均较儿童患者差。本研究显示,与单发病变相比,成人 IG 患者多发病灶与较低的 PFS 相关,且成人 IG 患者的 PFS 和 OS 较儿童 IG 患者差。对于多发病灶的成人 IG 患者,我们建议采用颅脊髓照射、全脑室照射(WVI)联合化疗,或仅接受 WVI 的患者频繁进行脊柱图像随访。